Steven Ramsay, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 Medical Park Dr, Atmore, AL 36502 Phone: 904-805-1300 Fax: 904-805-1302 |
Jeffrey Sloan, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 Medical Park Dr, Atmore, AL 36502 Phone: 904-805-1300 Fax: 904-805-1302 |
Robert A M Revel, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 401 Medical Park Dr, Atmore, AL 36502 Phone: 904-805-1300 Fax: 904-805-1302 |
Mark C D Mitchell, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 401 Medical Park Dr, Atmore, AL 36502 Phone: 904-805-1300 Fax: 904-805-1302 |
Dr. Jay Steven Scarborough, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 Medical Park Dr, Atmore, AL 36502 Phone: 251-368-2500 |
News Archive
Ingen Technologies, Inc., an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company revenues have increased from $10,401 reported in May 31, 2009, to $128,917 ending May 31, 2010. This is an increase of 1,139%.
The New York Times looks at the relationship between U.S. foreign aid's ability to shape aid recipients' attitudes toward the U.S. The article includes the perspectives of former USAID administrators J. Brian Atwood, who led the agency under President Bill Clinton, and Andrew Natsios, who was the director under President George W. Bush.
According to a recent poll of 1,000 American voters conducted for the American College of Radiology, nearly 9-in-10 women reported that having a regular mammogram gave them a feeling of control over their own health care. Nearly 90 percent of women who had a mammogram considered mammograms important to their health and well-being.
Scientists in a collaboration between EMBL Heidelberg and the University of Heidelberg Medical Centre have discovered how stressed cells boost the production of the key blood-clotting factor, thrombin. Their work, published today in Molecular Cell, shows how cancer cells may be taking advantage of this process, and opens new possibilities for fighting back against cancer and septicaemia.
› Verified 3 days ago